A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δ

Fragment-Based Drug Discovery (FBDD) has become, in recent years, a consolidated approach in the drug discovery process, leading to several drug candidates under investigation in clinical trials and some approved drugs. Among these successful applications of the FBDD approach, kinases represent a cl...

Full description

Bibliographic Details
Main Authors: Giovanni Bolcato, Eleonora Cescon, Matteo Pavan, Maicol Bissaro, Davide Bassani, Stephanie Federico, Giampiero Spalluto, Mattia Sturlese, Stefano Moro
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/18/9741
_version_ 1797518956313968640
author Giovanni Bolcato
Eleonora Cescon
Matteo Pavan
Maicol Bissaro
Davide Bassani
Stephanie Federico
Giampiero Spalluto
Mattia Sturlese
Stefano Moro
author_facet Giovanni Bolcato
Eleonora Cescon
Matteo Pavan
Maicol Bissaro
Davide Bassani
Stephanie Federico
Giampiero Spalluto
Mattia Sturlese
Stefano Moro
author_sort Giovanni Bolcato
collection DOAJ
description Fragment-Based Drug Discovery (FBDD) has become, in recent years, a consolidated approach in the drug discovery process, leading to several drug candidates under investigation in clinical trials and some approved drugs. Among these successful applications of the FBDD approach, kinases represent a class of targets where this strategy has demonstrated its real potential with the approved kinase inhibitor Vemurafenib. In the Kinase family, protein kinase CK1 isoform δ (CK1δ) has become a promising target in the treatment of different neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. In the present work, we set up and applied a computational workflow for the identification of putative fragment binders in large virtual databases. To validate the method, the selected compounds were tested in vitro to assess the CK1δ inhibition.
first_indexed 2024-03-10T07:36:37Z
format Article
id doaj.art-4a85a58ae9a34b8f8086f602bb1243d9
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T07:36:37Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-4a85a58ae9a34b8f8086f602bb1243d92023-11-22T13:26:50ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-09-012218974110.3390/ijms22189741A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δGiovanni Bolcato0Eleonora Cescon1Matteo Pavan2Maicol Bissaro3Davide Bassani4Stephanie Federico5Giampiero Spalluto6Mattia Sturlese7Stefano Moro8Molecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, ItalyDepartment of Chemical and Pharmaceutical Sciences, University of Trieste, Via Licio Giorgeri 1, 34127 Trieste, ItalyMolecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, ItalyMolecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, ItalyMolecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, ItalyDepartment of Chemical and Pharmaceutical Sciences, University of Trieste, Via Licio Giorgeri 1, 34127 Trieste, ItalyDepartment of Chemical and Pharmaceutical Sciences, University of Trieste, Via Licio Giorgeri 1, 34127 Trieste, ItalyMolecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, ItalyMolecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, ItalyFragment-Based Drug Discovery (FBDD) has become, in recent years, a consolidated approach in the drug discovery process, leading to several drug candidates under investigation in clinical trials and some approved drugs. Among these successful applications of the FBDD approach, kinases represent a class of targets where this strategy has demonstrated its real potential with the approved kinase inhibitor Vemurafenib. In the Kinase family, protein kinase CK1 isoform δ (CK1δ) has become a promising target in the treatment of different neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. In the present work, we set up and applied a computational workflow for the identification of putative fragment binders in large virtual databases. To validate the method, the selected compounds were tested in vitro to assess the CK1δ inhibition.https://www.mdpi.com/1422-0067/22/18/9741fragment-based drug discoverymolecular dockingmolecular dynamicssupervised molecular dynamicsprotein kinase CK1δ
spellingShingle Giovanni Bolcato
Eleonora Cescon
Matteo Pavan
Maicol Bissaro
Davide Bassani
Stephanie Federico
Giampiero Spalluto
Mattia Sturlese
Stefano Moro
A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δ
International Journal of Molecular Sciences
fragment-based drug discovery
molecular docking
molecular dynamics
supervised molecular dynamics
protein kinase CK1δ
title A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δ
title_full A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δ
title_fullStr A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δ
title_full_unstemmed A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δ
title_short A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δ
title_sort computational workflow for the identification of novel fragments acting as inhibitors of the activity of protein kinase ck1δ
topic fragment-based drug discovery
molecular docking
molecular dynamics
supervised molecular dynamics
protein kinase CK1δ
url https://www.mdpi.com/1422-0067/22/18/9741
work_keys_str_mv AT giovannibolcato acomputationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d
AT eleonoracescon acomputationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d
AT matteopavan acomputationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d
AT maicolbissaro acomputationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d
AT davidebassani acomputationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d
AT stephaniefederico acomputationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d
AT giampierospalluto acomputationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d
AT mattiasturlese acomputationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d
AT stefanomoro acomputationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d
AT giovannibolcato computationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d
AT eleonoracescon computationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d
AT matteopavan computationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d
AT maicolbissaro computationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d
AT davidebassani computationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d
AT stephaniefederico computationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d
AT giampierospalluto computationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d
AT mattiasturlese computationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d
AT stefanomoro computationalworkflowfortheidentificationofnovelfragmentsactingasinhibitorsoftheactivityofproteinkinaseck1d